Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 968 of 5804
-
New pill takes on rare, stubborn lymphoma
Disease control Recruiting nowThis is a Phase Ib in adult patients with relapsed or refractory EBV-positive DLBCL using daily oral dosing of VK-2019 in three dose escalation cohorts: 600 mg/day, 1200 mg/day, 1800 mg/day for 28 days (cycle), until progression or toxicity.
Phase: PHASE1 • Sponsor: Pierluigi Porcu • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New study tests lifestyle program to stop gestational diabetes before it starts
Prevention Not yet recruitingThe goal of this study is assess the impact of a higher intensity dietary and activity counseling program to improve blood sugar control and reduce the chance of developing gestational diabetes (GDM) as compared to the current standard diet and activity counseling.
Phase: NA • Sponsor: Indiana University • Aim: Prevention
Last updated Jun 27, 2026 08:05 UTC
-
New drug aims to build muscle in rare muscular dystrophy
Disease control Not yet recruitingA randomized Phase 2 study to evaluate the efficacy and safety of apitegromab as a monotherapy in participant with FSHD
Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug cocktail shows promise for tough bile duct cancer
Disease control Not yet recruitingThis study aims to observe the efficacy and safety of the combination of vebecotototo monoclonal antibody and putli monoclonal antibody in the treatment of EGFR-positive refractory biliary malignant tumors.
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Urine test could revolutionize thyroid cancer Follow-Up
Knowledge-focused Not yet recruitingThyroid cancer is the most common endocrine malignancy, and although differentiated thyroid cancer (DTC) generally confers favorable outcomes, 10-20% of patients still face substantial postoperative risks, including local recurrence, distant metastasis, and inadequate response to…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New transplant cocktail aims to tame blood cancer without severe side effects
Disease control Recruiting nowThis phase 1 trial will investigate the safety and effectiveness of Thiotepa, Busulfan, and Fludarabine (TBF) conditioning regimen with post-transplant cyclophosphamide (PTCy) in HLA-matched related or unrelated donor allogeneic stem cell transplantation (alloSCT).
Phase: PHASE1 • Sponsor: Sawa Ito, MD • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a common antibiotic ease Kids' bowel disease?
Disease control Not yet recruitingThe goal of this clinical trial is to learn how oral vancomycin therapy may contribute in treating paediatric inflammatory bowel disease, particularly atypical ulcerative colitis and PSC-associated colitis. It will also give more information on how this treatment affects gut micr…
Phase: PHASE2 • Sponsor: Tampere University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Dog allergy vaccine shows promise in small swedish trial
Disease control Recruiting nowSTUDY DESIGN A single-center prospective before-and-after study evaluating the effect of Alutard SQ Dog in 40 men and women with moderate-to-severe dog allergy. Participants will serve as their own controls. STUDY OUTLINE The study will begin in the fall of 2026 and will be con…
Phase: PHASE4 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New study compares two inhaled steroids for treating wheezing in babies
Disease control Not yet recruitingThis study looks at how well and how safe fluticasone propionate nebulized suspension works in babies aged 0 to 24 months who have acute wheezing. Investigators will compare it to budesonide nebulized suspension, another approved inhaled steroid. About 240 babies will join. Par…
Phase: PHASE4 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could an asthma drug help fight lung cancer? early trial investigates
Disease control Not yet recruitingBrief Summary This prospective, open-label pilot study is designed to evaluate the safety, tolerability, feasibility, and preliminary clinical activity of inhaled cromolyn sodium administered by dry powder inhalation in participants with locally advanced lung cancer. Cromolyn s…
Phase: PHASE1 • Sponsor: Carcinex Inc • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can heat boost chemo? early trial tests thermotherapy for head and neck cancer
Disease control Not yet recruitingThis phase I, single-center study evaluates the safety, tolerability, and recommended phase II dose (RP2D) of mild hyperthermia (thermotherapy) when added to standard-of-care treatment in patients with locally advanced head and neck squamous cell carcinoma (LAHNSCC). Tumor recurr…
Phase: PHASE1 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a sleep therapy and melatonin combo help older adults beat chronic insomnia?
Symptom relief Not yet recruitingThis study tests the efficacy of cognitive behavioural therapy for insomnia (CBT-I) with or without adjunct melatonin in older adults with insomnia. Adults aged 60 or above with chronic insomnia will be randomly assigned to one of three groups: (1) CBT-I plus nightly melatonin, (…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Microembolization may outlast steroid shots for frozen shoulder
Disease control Not yet recruitingObjectives: This study aims to compare the efficacy of transcatheter arterial microembolization (TAME) and corticosteroid injection for treatment of frozen shoulder. Background: Frozen shoulder (adhesive capsulitis) is a common condition that leads to significant functional impa…
Phase: NA • Sponsor: Shin Kong Wu Ho-Su Memorial Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Zapping the brain to ease chemo nerve pain: a new hope for breast cancer survivors
Symptom relief Not yet recruitingChemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating complication among breast cancer survivors, frequently associated with chronic neuropathic pain that remains inadequately controlled by pharmacological treatments. Emerging evidence suggests that CIPN …
Phase: NA • Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Smart T-Cell engager aims to outsmart tumors in first human test
Disease control Not yet recruitingThis is a first-in-human, open-label, multicenter, Phase I study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics (PK/PD), and preliminary antitumor activity of single-agent KGX105 in participants with locally advanced or metastatic solid tumors. The study …
Phase: PHASE1 • Sponsor: Kangabio AUSTRALIA LTD PTY • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Smartwatch could alert doctors to brain cancer complications before they worsen
Disease control Not yet recruitingThis research study is for participants diagnosed with leptomeningeal metastasis disease (LMM), a condition where cancer has spread to the fluid and membranes surround the brain and spinal cord. The purpose of this study is to find out whether a consumer Smartwatch can continuous…
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Robotic glove and virtual reality team up to rehabilitate Stroke-Affected hands
Disease control Not yet recruitingThis pilot study will test whether the GRIP program-a soft robotic glove with virtual-reality training-can improve hand and arm function in adults undergoing inpatient rehabilitation after a recent stroke. About 20 participants will be randomly assigned to either the GRIP program…
Phase: NA • Sponsor: Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could removing lead protect kidneys in diabetes?
Disease control Not yet recruitingThis is a single-arm prospective clinical study conducted at The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Previous basic research has found that patients with type 2 diabetic nephropathy have higher blood lead levels than ordinary people, and lead acc…
Phase: NA • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New sleep drug aims to help Parkinson's patients get a good Night's rest
Symptom relief Not yet recruitingThis study will use sleep parameters measured by polysomnography (PSG) as the primary means to evaluate the efficacy and safety of dimdazenil, a GABAA receptor partial agonist, in treating insomnia in Parkinson's disease patients.
Sponsor: Second Affiliated Hospital of Soochow University • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Can a single cream tackle both skin and nail psoriasis?
Disease control Not yet recruitingThis is an open label trial in subjects ≥12 years of age and older with chronic plaque psoriasis and moderate to severe nail psoriasis. Eligible participants will apply roflumilast 0.3% cream daily for 24 weeks to affected nails daily for the entire study duration and to psorias…
Phase: PHASE4 • Sponsor: Modern Research Associates, PLLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC